BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Almeida NS, Rocha R, de Souza CA, da Cruz ACS, Ribeiro BDR, Vieira LV, Daltro C, Silva R, Sarno M, Cotrim HP. Prevalence of sarcopenia using different methods in patients with non-alcoholic fatty liver disease. World J Hepatol 2022; 14(8): 1643-1651 [PMID: 36157861 DOI: 10.4254/wjh.v14.i8.1643]
URL: https://www.wjgnet.com/1948-5182/full/v14/i8/1643.htm
Number Citing Articles
1
Gyu Bae Lee, Youn Huh, Sang Hyun Lee, Byoungduck Han, Yang-Hyun Kim, Do-Hoon Kim, Seon Mee Kim, Youn Seon Choi, Kyung Hwan Cho, Ga Eun Nam. Association of low muscle strength with metabolic dysfunction-associated fatty liver disease: A nationwide studyWorld Journal of Gastroenterology 2023; 29(45): 5962-5973 doi: 10.3748/wjg.v29.i45.5962
2
Thais Pontello de Vries, Aline Marcos Pires, Kiara Gonçalves Dias Diniz, Anna Luiza Soares Chagas, Diego Alves Vieira, Adriana Maria Kakehasi, Vivian Marques Miguel Suen, Tatiana Bering, Enrico Antonio Colosimo, Gifone Aguiar Rocha, Kátia de Paula Farah, Luciana Diniz Silva. Agreement and diagnostic differences among three definitions of sarcopenia in patients with chronic hepatitis CNutrition in Clinical Practice 2024; 39(3): 568 doi: 10.1002/ncp.11141
3
Suprabhat Giri, Prajna Anirvan, Sumaswi Angadi, Ankita Singh, Anurag Lavekar. Prevalence and outcome of sarcopenia in non-alcoholic fatty liver diseaseWorld Journal of Gastrointestinal Pathophysiology 2024; 15(1): 91100 doi: 10.4291/wjgp.v15.i1.91100
4
Alessandra Musio, Federica Perazza, Laura Leoni, Bernardo Stefanini, Elton Dajti, Renata Menozzi, Maria Letizia Petroni, Antonio Colecchia, Federico Ravaioli. Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver DiseaseInternational Journal of Molecular Sciences 2023; 24(8): 7517 doi: 10.3390/ijms24087517
5
Tingwan Du, Lian Xiang, Jingjing Zhang, Chunmei Yang, Wenxin Zhao, Jialu Li, Yong Zhou, Ling Ma. Vitamin D improves hepatic steatosis in NAFLD via regulation of fatty acid uptake and β-oxidationFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1138078
6
Christine L. Freer, Elena S. George, Sze-Yen Tan, Gavin Abbott, David Scott, Robin M. Daly. Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK BiobankCalcified Tissue International 2024;  doi: 10.1007/s00223-024-01212-5